Digital Pathology Systems

Global Market Trajectory & Analytics

MCP-6740

EXECUTIVE ENGAGEMENTS

OUTREACH

2281
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

411
Interactions with Platform & by Email

PARTICIPANTS

68
Unique # Participated

VALIDATIONS

31
Responses Validated*

COMPETITORS

74
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

300

PAGES

620

EDITION

15

PRICE

USD $5450


  

HIGHLIGHTS

The global market for Digital Pathology Systems is expected to witness demand spike by 18.3% in the year 2020 highlighting a US$89.1million gains in annual revenue. Thereafter the market is expected to accelerate further and reach US$1.4 billion by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027.Pathology plays a huge role in the healthcare system and is a key part of clinical decision support. The pandemic has catalyzed the urgency of going digital and health systems are responding at lightning speeds. From telemedicine, wearable`s, IR monitoring to automation via use of robots, technology adoption is swift to ensure uninterrupted non-COVID care delivery with minimal infection risks. Deployment of IT is also gaining swift momentum as evidenced by rising demand for cloud solutions; analytics; sustainable supply chain solutions; EMR, EHR & digital pathology systems. With stay-at-home restrictions and the FDA`s decision to relax existing guidelines, various anatomic pathologists are embracing digital pathology to review images and slides from home. COVID-19 has resulted in dramatic decline in specimen referrals and associated revenues at anatomic pathology laboratories and groups. With the pandemic curtailing all but the most urgent cancer treatments and surgeries, histology laboratories are typically receiving extremely challenging tissue specimens for processing. In addition, there is a growing shortage of pathologists worldwide, with medical students entering the field failing to keep pace with the rate of retiring pathologists. Moreover, the strict physical distancing norms imposed to curb the spread of COVID-19 have led pathologists to stay of the lab.


However, amid the COVID-19 outbreak, new rules have been developed for allowing the increased usage of digital pathology and reading and reviewing of pathology slides and test results remotely, provided the test was initially performed in a CLIA-authorized laboratory. The pandemic prompted the CMS to ease restrictions for allowing pathologists to work and review pathology images remotely to reduce the risk of exposure to the virus. Applicable during the pandemic, the decision is bound to push capacity by supporting remote review of clinical results, laboratory data and pathology slides. The US FDA has temporarily eased guidelines pertaining to digital pathology services for encouraging medical professionals to remotely review scanned slides during COVID-19. The adoption of digital pathology is anticipated to reduce the exposure of pathologists to the virus and prevent disruption to critical pathology services. The new policy is applicable to Class-II digital pathology devices, and follows the CMS` decision to provide pathologists with the flexibility to remotely review clinical data, pathology studies and results during the outbreak. Prior to the COVID-19 pandemic, CMS guidelines under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 prohibited clinicians from making primary diagnoses remotely. The regulation made it mandatory for pathologists to work in healthcare settings, hospitals or clinical laboratories holding the CLIA license. However, the pandemic prompted the CMS to suspend these requirements and allow pathologists to interpret and review cases remotely. The new policy from the FDA also allows the use of consumer monitors instead of medical-grade monitors. Pathologists can access images remotely over a secure VPN Internet connection to make diagnosis. In addition, the agency is making efforts to ensure access to remote digital pathology systems or devices amid the pandemic.


In short, although the world is in recession, it is not doomsday for digital health companies and VC funding will continue to increase given the unprecedented demand for digital health technology solutions. Future growth in the market will be driven by ever growing workload of pathologists; growing emphasis on quality of care and the resulting need for efficient, faster and cost-effective methods for accurate pathological assessment; and need for compliance with regulatory standards related to information management. Few of the benefits of digital pathology driving its adoption include digitalization of workflows; unification of patient data for more informed decision making; exposure to new clinical insights and data which adds to the volume of available expert knowledge; enables multi-disciplinary care by connecting multiple medical teams; enhanced workflow efficiency, reduced costs of operating pathological processes, quicker acquisition of high resolution images, and faster and accurate diagnosis. As healthcare moves to a value based system, zero tolerance to innate delays built into traditional pathology processes will drive growth of digital pathology systems. Focus on developing coherent and sustainable plans to address healthcare needs of the masses will drive increased investments in healthcare IT, especially in developing countries. Fully automated digital pathology are poised to witness strong growth in demand amid the rising emphasis on lab automation. Developments in laboratory information management system (LIMS) and network connectivity and speeds to enable digital pathology deliver on its promise of reduced diagnostic time in comparison with traditional microscopy will also be crucial to growth in the market. In addition, focus on disease prevention, early diagnosis and intervention will remain evergreen factors driving routine use of digital pathology services.

SELECT PLAYERS

3DHISTECH Ltd.; Apollo Enterprise Imaging Corp.; Carl Zeiss AG; Corista LLC; Glencoe Software, Inc; Hamamatsu Photonics K.K.; Huron Digital Pathology, Inc.; Indica Labs; Inspirata Inc; KANTERON SYSTEMS S.L.U; KONFOONG BIOTECH INTERNATIONAL CO.,LTD; Leica Biosystems Nussloch GmbH; MikroScan Technologies; Inc.; Objective Pathology Services; Olympus Corporation; OptraSCAN, Inc; Philips Healthcare; Proscia Inc; Sectra AB; Visiopharm A/S

SEGMENTS

» Segment (Device, Software, Other Segments) » Type (Human Pathology, Veterinary Pathology) » End-Use (Pharma & Biotech Companies, Hospitals & Reference Labs, Academic & Research Institutes)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
EXHIBIT: Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
EXHIBIT: % Share VC Investments by Category for 2020
FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
Future Outlook of Pathology Post-COVID-19
Digital Pathology: An Introduction
Key Digital Pathology Tools
Market Outlook
US and Europe Maintain Dominance
Emerging Markets to Experience Strong Growth
Scanners Lead Digital Pathology Market
Software Segment Post Strong Growth
Disease Diagnosis: Major Application of Digital Pathology Systems
Telepathology Experiences Strong Growth
Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
EXHIBIT: Global Digital Pathology Systems Market by End-Use: 2020
Major Issues Hampering Adoption of Digital Pathology Systems
Competitive Landscape
EXHIBIT: Market Share of Leading Players in Digital Pathology Systems Market: 2020E
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Advancements Drive Adoption of Digital Pathology Systems
Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
Advantages of AI-Powered Digital Pathology
Digital Pathology Benefits Drug Discovery Process
Need for Early Diagnosis Puts Focus on Digital Pathology
Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
EXHIBIT: Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
Clinical Research Continues to be Core Vertical for Digital Pathology
Digital Imaging and Robotic Light Microscopy Boost Growth
Computational Pathology for Leading-Edge Image Analytics
Cloud Platform Gains Momentum
Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
Increased Focus on Companion Diagnostics to Benefit Market Growth
Improving Healthcare & Research Expenditure to Support Growth
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population: A Key Opportunity Indicator
EXHIBIT: Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
EXHIBIT: Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
EXHIBIT: Global Cancer Deaths by Age Group (in %) for 2019
Challenges Facing Digital Pathology Systems Market
High Costs
Workflow Integration with Other Related Functions
Other Issues
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2020 & 2027
World Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
UNITED STATES
COVID-19 Triggers Demand for Digital Pathology
Market Overview
Increasing Pressure on Pathological Labs: Cornerstone for Growth
USA Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
USA Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
USA Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
CANADA
Canada Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Canada Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Canada Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
JAPAN
Market Overview
Japan Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Japan Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Japan Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
CHINA
Market Overview
China Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
China Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
China Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
EUROPE
Market Overview
Europe Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2020 & 2027
Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
FRANCE
France Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
France Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
France Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Germany Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Germany Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
ITALY
Italy Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Italy Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Italy Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
UK Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
UK Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Spain 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Spain Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Spain 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Spain Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Spain 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Russia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Russia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Russia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Russia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Russia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Rest of Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Rest of Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
ASIA-PACIFIC
Market Overview
Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2020 & 2027
Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Australia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Australia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Australia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Australia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Australia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
INDIA
Market Overview
Inadequate Infrastructure Impedes Adoption of Telepathology
India Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
India 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
India Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
India 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
India Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
India 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
South Korea 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
South Korea Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
South Korea 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
South Korea Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
South Korea 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Latin America 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2020 & 2027
Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Argentina 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Argentina Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Argentina 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Argentina Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Argentina 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Brazil 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Brazil Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Brazil 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Brazil Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Brazil 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Mexico 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Mexico Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Mexico 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Mexico Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Mexico 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Rest of Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Middle East 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2020 & 2027
Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
IRAN
Iran Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Iran 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Iran Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Iran 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Iran Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Iran 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Israel 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Israel Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Israel 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Israel Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Israel 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Saudi Arabia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Saudi Arabia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UAE 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
UAE Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UAE 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
UAE Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
UAE 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Rest of Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Africa 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
Africa Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Africa 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
Africa Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
Africa 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
Total Companies Profiled: 74

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com